2022 - Research.com Medicine in Austria Leader Award
Werner Poewe focuses on Parkinson's disease, Internal medicine, Disease, Psychiatry and Physical therapy. His Parkinson's disease study combines topics in areas such as Anesthesia, Placebo, Central nervous system disease and Parkinsonism. Werner Poewe has researched Internal medicine in several fields, including Gastroenterology and Endocrinology.
The concepts of his Disease study are interwoven with issues in Depression and Intensive care medicine. His research integrates issues of Dementia, MEDLINE, Clinical psychology and Rating scale in his study of Psychiatry. His work carried out in the field of Physical therapy brings together such families of science as Pure autonomic failure, Clinical research, Severity of illness and Quality of life.
Werner Poewe spends much of his time researching Parkinson's disease, Internal medicine, Disease, Atrophy and Physical therapy. The Parkinson's disease study combines topics in areas such as Psychiatry, Central nervous system disease, Physical medicine and rehabilitation and Parkinsonism. As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Placebo and, on occasion, Adverse effect, Tolerability and Pramipexole.
His Disease study combines topics from a wide range of disciplines, such as Pediatrics and Intensive care medicine. His Atrophy research incorporates themes from Neurology and Neuroscience. His Physical therapy research is multidisciplinary, incorporating perspectives in Quality of life, Severity of illness and Rating scale.
His primary areas of study are Parkinson's disease, Internal medicine, Atrophy, Disease and Levodopa. The study incorporates disciplines such as Post-hoc analysis, Clinical trial, Physical medicine and rehabilitation and Parkinsonism in addition to Parkinson's disease. His Internal medicine research includes themes of Gastroenterology, Placebo, Neurology and Cardiology.
His Atrophy research also works with subjects such as
Werner Poewe mainly investigates Parkinson's disease, Internal medicine, Atrophy, Clinical trial and Disease. His Parkinson's disease research is multidisciplinary, incorporating perspectives in Physical medicine and rehabilitation, Differential diagnosis, Disease duration and Parkinsonism. His Internal medicine research integrates issues from Oncology and Rating scale.
His research in Atrophy intersects with topics in Gastroenterology, Radiology, Retrospective cohort study and Putamen. As a part of the same scientific family, Werner Poewe mostly works in the field of Clinical trial, focusing on Placebo and, on occasion, Levodopa, Randomized controlled trial and Dyskinesia. His Disease research incorporates themes from Epidemiology, Immune system, Immunotherapy and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Günther Deuschl;Carmen Schade-Brittinger;Paul Krack;Jens Volkmann.
The New England Journal of Medicine (2006)
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn.
Movement Disorders (2007)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman;G. K. Wenning;P. A. Low;D. J. Brooks.
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Christopher G. Goetz;Werner Poewe;Olivier Rascol;Cristina Sampaio.
Movement Disorders (2004)
Rivastigmine for Dementia Associated with Parkinson's Disease
Murat Emre;Dag Aarsland;Alberto Albanese;E. Jane Byrne.
The New England Journal of Medicine (2004)
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe.
Movement Disorders (2007)
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone;Ray L Watts;A Jon Stoessl;Margaret Davis.
Annals of Neurology (2003)
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
Bruno Dubois;David Burn;Christopher Goetz;Dag Aarsland;Dag Aarsland.
Movement Disorders (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: